Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block ...
Apr 30, 2024
0
39
Obesity is a major risk factor for metabolic disorders including non-alcoholic fatty liver disease and type 2 diabetes. It has been reported that non-alcoholic fatty liver disease doubles the likelihood of developing type ...
Aug 9, 2023
0
12
There are about 700,000 children living with childhood dementia around the world, which is caused by more than 70 rare genetic conditions.
Apr 17, 2023
0
2
It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related liver diseases. When fat accumulation occurs in the liver even ...
Sep 13, 2022
0
7
A study published in Aging Cell and conducted in the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, revealed that menopausal transition increases women's body fat, especially in the waist ...
May 19, 2022
0
1
A new study offers the first evidence that a protein named BAM15 acts as an energy uncoupler and could be an effective drug for treating obesity and related diseases.
Jun 10, 2020
1
145
In Germany about 18 million people suffer from non-alcoholic fatty liver. The causes of this disease are manifold and include environmental as well as genetic factors. DZD researchers have now discovered new genes that play ...
May 19, 2020
0
2
Every-other-day fasting substantially reduces the likelihood of developing type 2 diabetes in mice eating a fat-rich diet, according to new research out of the German Institute of Human Nutrition Potsdam-Rehbruecke. These ...
Jul 10, 2019
0
0
Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver. DZD scientists from DIfE have now discovered that mice on an intermittent fasting regimen ...
Jul 2, 2019
0
3
A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating the interleukin 11 (IL11) protein with therapeutic antibodies reverses inflammation and scarring of the ...
May 23, 2019
0
226
